Effect of N-acetylcysteine as adjunct therapy versus placebo on clinical outcomes and serum levels of oxidative stress biomarkers in patients with systolic heart failure
Phase 2
Recruiting
- Conditions
- Systolic heart failure.Systolic (congestive) heart failureI50.2
- Registration Number
- IRCT20120215009014N333
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age of 18 to 80 years,
Systolic heart failure,
Constant drug treatment for heart failure for at least 2 months,
Stable clinical and hemodynamic status,
Exclusion Criteria
Pregnancy or breastfeeding,
Concomitant chronic liver, kidney or respiratory diseases,
History of myocardial infarction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method